The International Society of Microbiota (ISM) has announced the launch of a new initiative: The Phage-Microbiome Consortium.
This project’s primary goal is to establish a consortium of world-renowned experts specializing in bacteriophages and the human microbiome. The consortium will embark on an ambitious journey to explore and better understand the critical role bacteriophages can play in shaping and modulating the microbiome in the context of human health and disease.
ISM says it believes that this collaborative research effort, combined with an open platform for knowledge exchange, will break down the barriers of current knowledge and reveal fresh insights into the intricacies of our microbiome.
The Phage-Microbiome Consortium will engage in a cooperative and innovative approach to scientific exploration. Its teams of researchers, assembled from global microbiome and phage experts, will push the frontiers of microbiome science, creating transformative knowledge for human health and well-being.
“The Phage-Microbiome Consortium is an important step forward for the microbiome field. This initiative will not only advance our understanding of the intricate relationship between bacteriophages and the microbiome, but also will provide crucial insights that could lead to innovative strategies for managing human health and disease,” said Marvin Edeas, MD, PhD, Chairman of the Scientific committee and ISM founder.
The ISM invites scientists, researchers, and interested parties from around the world to join this consortium and contribute to this groundbreaking exploration of the phage-microbiome interplay.
For more information about The Phage-Microbiome Consortium, modality of submission, funding and more, visit the website or contact firstname.lastname@example.org.
During the 10th World Congress on Targeting Microbiota 2023, which will be held on October 17-19 in Venice, the scientific committee will choose and finalize the members of the Consortium.